Aclarion, Inc.

Contributing Author

Recent Articles by Aclarion, Inc.

May-07	Aclarion Announces Addition of First Private Practice Site in Los Angeles into CLARITY Trial to Further Accelerate Enrollment ACON GlobeNewswire
May-06	Aclarion Announces Inducement Grant to New Commercial Director, Western U.S. ACON GlobeNewswire
May-05	Aclarion Announces Second Commercial Agreement with Weill Cornell Medicine ACON GlobeNewswire
Apr-30	Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical Adoption ACON GlobeNewswire
Apr-28	Aclarion Appoints Daniel Keefe as Commercial Director, Western U.S., to Drive Continued Adoption of Nociscan ACON GlobeNewswire
Apr-22	Aclarion Announces $2.5 Million Stock Repurchase Plan ACON +5.67% GlobeNewswire
Apr-16	Aclarion Secures U.S. Patent Advancing Scalable, AI-Driven Assessment of Chronic Low Back Pain ACON GlobeNewswire
Apr-14	Aclarion Receives Pinnacle Award for AI Innovation ACON GlobeNewswire
Apr-08	Aclarion Announces Agreement with Weill Cornell Medicine ACON GlobeNewswire
Apr-07	Aclarion Highlights Growing Adoption of Nociscan at The London Clinic with New Physician Video ACON GlobeNewswire
Mar-19	Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan ACON GlobeNewswire
Mar-19	Aclarion Publishes CEO Shareholder Letter Highlighting Strategic Progress and 2026 Catalysts ACON GlobeNewswire
Mar-17	Aclarion to Participate in the 38th Annual ROTH Conference, Highlighting Key 2026 Catalysts and Strong Balance Sheet ACON GlobeNewswire
Mar-12	Aclarion CEO Brent Ness to Attend LSI USA 2026 ACON GlobeNewswire
Feb-05	Aclarion Publishes 2026 Shareholder Letter from the Chairman ACON -12.59% GlobeNewswire
Feb-03	Aclarion Adds High-Volume Practice, Source Healthcare, to Support Nociscan Growth and Real-World Evidence Generation ACON GlobeNewswire
Jan-13	Aclarion Strengthens Balance Sheet and Extends Cash Runway Into 2028 ACON -6.87% GlobeNewswire
Jan-08	Aclarion Provides 2025 Update and 2026 Corporate Outlook ACON +42.09% GlobeNewswire
Jan-06	Aclarion Announces First Patient Enrollments at Two Additional CLARITY Trial Sites and Provides Guidance on Expected Availability of Initial Data ACON GlobeNewswire
Dec-04	Aclarion Announces Publication of Nociscan Article in Special Pain Issue of the International Journal of Spine Surgery (IJSS) ACON +5.55% GlobeNewswire
Dec-02	Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S. ACON +10.31% GlobeNewswire
Nov-05	Aclarion Appoints Dan Isherwood as UK Commercial Director to Drive Adoption and Market Expansion ACON GlobeNewswire
Oct-22	Aclarion Wins "Rising Star" at 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH ACON GlobeNewswire
Oct-14	Aclarion Provides Corporate Update Highlighting Market Expansion as CLARITY Trial Advances Toward Key Data Catalyst ACON -7.64% GlobeNewswire
Oct-13	Aclarion Announces Use of MR Spectroscopy for identifying Biomarkers of Discogenic Pain highlighted at Global Neuroscience Conference ACON +12.71% GlobeNewswire
Oct-07	Aclarion Honored as Finalist for the 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH ACON GlobeNewswire
Oct-01	Aclarion Presents at LSI Europe '25 Highlighting Nociscan Technology and Key Value Drivers ACON GlobeNewswire
Sep-25	First Patients Enrolled at UHealth - University of Miami in Aclarion's Pivotal CLARITY Trial ACON GlobeNewswire
Sep-03	Aclarion Appoints Greg Gould as Chief Financial Officer ACON GlobeNewswire
Aug-05	Aclarion Provides Corporate Update Highlighting Scan Volume Growth and Key Upcoming Catalysts ACON +5.71% GlobeNewswire
Jul-07	Aclarion, Inc. Announces Adjournment of Annual Meeting of Stockholders ACON GlobeNewswire
Jun-25	First Patient Enrolled in Aclarion's Groundbreaking CLARITY Trial ACON GlobeNewswire
Jun-24	Aclarion to Present NOCISCAN Technology at Leading Spine Innovation Forum ACON GlobeNewswire
Jun-10	Aclarion Adds UHealth, University of Miami Miller School of Medicine as CLARITY Trial Site ACON GlobeNewswire
May-20	Aclarion Announces Addition of Keck Medical Center of USC as CLARITY Trial Site ACON GlobeNewswire
May-12	Aclarion Announces Texas Back Institute as New CLARITY Trial Site ACON +7.04% GlobeNewswire
May-05	Aclarion Welcomes Advocate Health as CLARITY Trial Site ACON GlobeNewswire

Aclarion, Inc.

Recent Articles by Aclarion, Inc.

Upgrade your Finviz experience